Article
Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients.
Genes, chromosomes & cancer - 1 Dec 2016
Cardoso Marta, Paulo Paula, Maia Sofia, Teixeira Manuel R
Abstract excerpt
Truncating activating mutations in the last exon of PPM1D have been described in patients with breast, ovarian, colorectal and non-small cell lung cancer, but recent data indicate that they may be associated with previous chemotherapy. In this study we evaluated the prevalence of PPM1D mutations in white blood cells (WBC) of 462 patients with early-onset and/or familial/hereditary prostate cancer (PrCa) by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
